Suppressive Effects of the Flavonoids Quercetin and Luteolin on the Accumulation of Lipid Rafts after Signal Transduction via Receptors

REFERENCES

• K. Kawaguchi, H. Maruyama, H. Hasegawa, S. Kikuchi, H. Morita, and Y. Kumazawa. (1999). Suppression of lipopolysaccharide-induced tumor necrosis factor-release and liver injury in mice by naringin. Eur. J. Pharmacol. 368 (2–3):245–250.
   PubMedGoogle Scholar
• K. Kawaguchi, S. Kikuchi, R. Hasunuma, H. Maruyama, R. Ryll, and Y. Kumazawa. (2004). Suppression of infection-induced endotoxin shock in mice by a Citrus flavanone naringin. Planta Medica 70 (1):17–22.
   PubMedGoogle Scholar
• K. Kawaguchi, S. Kikuchi, R. Hasunuma, H. Maruyama, T. Yoshikawa, and Y. Kumazawa. (2004). A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice. Biol. Pharm. Bull. 27 (5):679–683.
   PubMedGoogle Scholar
• K. Kawaguchi, H. Maruyama, T. Kometani, and Y. Kumazawa. (2006). Suppression of collagen-induced arthritis by oral administration of the citrus flavonoid hesperidin. Planta Medica 72 (5):477–479.
   PubMedGoogle Scholar
• M. Feldmann, and R.N. Maini. (2001). Anti-TNFα therapy of rheumatoid arthritis: What have we learned?. Ann. Rev. Immunol. 19:163–196.
   PubMed Web of Science ®Google Scholar
• W.B. Graninger, and J.S. Smolen. (2001). One-year inhibition of tumor necrosis factor-α: A major success or a larger puzzle?. Curr. Opin. Rheum. 13 (3):209–213.
   PubMedGoogle Scholar
• J.C. Shanahan, and W. St. Clair. (2002). Tumor necrosis factor-α blockade: A novel therapy for rheumatic disease. Clin. Immunol. 103 (3 Pt 1):231–242.
   PubMedGoogle Scholar
• T.R. Mikuls, and A.L. Weaver. (2003). Lessons learned in the use of tumor necrosis factor-α inhibitors in the treatment of rheumatoid arthritis. Curr. Rheum. Reports 5 (4):270–277.
   PubMedGoogle Scholar
• P.C. Taylor. (2003). Anti-TNFα therapy for rheumatoid arthritis: An update. Int. Med. 42 (1):15–20.
   PubMedGoogle Scholar
• H.M. Herath, Y. Takano-Ishikawa, and K. Yamaki. (2003). Inhibitory effect of some flavonoids on tumor necrosis factor-α production in lipopolysaccharide-stimulated mouse macrophage cell line J774.1. J. Med. Food 6 (4):365–370.
   PubMedGoogle Scholar
• Y. Kumazawa, K. Kawaguchi, and H. Takimoto. (2006). Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor α. Curr. Pharm. Des. 12 (32):4271–4279.
   PubMedGoogle Scholar
• K.R. Manjeet, and B. Ghosh. (1999). Quercetin inhibits LPS-induced nitric oxide and tumor necrosis factor-α production in murine macrophages. Int. J. Immunopharmacol. 21 (7):435–443.
   PubMedGoogle Scholar
• A. Xagorari, C. Roussos, and A. Papapetropoulos. (2002). Inhibition of LPS-stimulated pathways in macrophages by the flavonoid luteolin. Br. J. Pharmacol. 136 (7):1058–1064.
   PubMedGoogle Scholar
• H. Ueda, C. Yamazaki, and M. Yamazaki. (2004). A hydroxyl group of flavonoids affects oral anti-inflammatory activity and inhibition of systemic tumor necrosis factor-α production. Biosci. Biotechnol. Biochem. 68 (1):119–125.
   PubMedGoogle Scholar
• E.K. Fridriksson, P.A. Shipkova, E.D. Sheets, D. Holowka, B. Baiard, and F.W. McLafferty. (1999). Quantitative analysis of phospholipids in functionally important membrane domains from RBL-2H3 mast cells using tandem high-resolution mass spectrometry. Biochem. 38 (25):8056–8063.
   PubMedGoogle Scholar
• C. Langlet, A.-M. Bernard, P. Drevot, and H.T. He. (2000). Membrane rafts and signaling by the multichain immune recognition receptors. Curr. Opin. Immunol. 12 (3):250–255.
   PubMedGoogle Scholar
• A. Cherukuri, M. Dykstra, and S.K. Pierce. (2001). Floating the raft hypothesis: Lipid rafts play a role in immune cell activation. Immunity 14 (6):657–660.
   PubMedGoogle Scholar
• K. Saeki, Y. Miura, D. Aki, T. Kurosaki, and A. Yoshimura. (2003). The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J. 22 (12):3015–3026.
   PubMedGoogle Scholar
• C. Montixi, C. Langlet, A.M. Bernard, J. Thimonier, C. Dubois, M.A. Wurbel, J.P. Chauvin, M. Pierres, and H.T. He. (1998). Engagement of T cell receptor triggers its recruitment to low-density detergent-insoluble membrane domains. EMBO J. 17 (18):5334–5348.
   PubMedGoogle Scholar
• R. Xavier, T. Brennan, Q. Li, C. McCormack, and B. Seed. (1998). Membrane compartmentation is required for efficient T cell activation. Immunity 8 (6):723–732.
   PubMedGoogle Scholar
• Y. Yashiro-Ohtani, X.Y. Zhou, K. Toyo-Oka, X.G. Tai, C.S. Park, T. Hamaoka, R. Abe, K. Miyake, and H. Fujiwara. (2000). Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts. J. Immunol. 164 (3):1251–1259.
   PubMedGoogle Scholar
• M.A. Alonso, and J. Millán. (2001). The role of lipid rafts in signaling and membrane trafficking in T lymphocytes. Journal of Cell Sci. 114 (22):3957–3965.
   PubMedGoogle Scholar
• K. Busam, C. Gieringer, M. Freudenberg, and H.P. Hohmann. (1992). Staphylococcus aureus and derived exotoxins induce nuclear factor κB-like activity in murine bone marrow macrophages. Infect. Immun. 60 (5):2008–2015.
   PubMedGoogle Scholar
• R. Hasunuma, H. Morita, S. Tanaka, R. Ryll, M.A. Freudenberg, C. Galanos, and Y. Kumazawa. (2001). Differential clearance and induction of host responses by various administered or released lipopolysaccharides. J. Endotoxin Res. 7 (6):421–429.
   PubMedGoogle Scholar
• Q. Yang, W. Huang, C. Jozwik, Y. Lin, M. Glasman, H. Caohuy, M. Srivastava, D. Esposito, W. Gillette, J. Hartley, and H.B. Pollard. (2005). Cardiac glycosides inhibit TNF-α/NF-κB signaling by blocking recruitment of TNF receptor-associated death domain to the TNF receptor. Proc. Natl. Acad. Sci. U. S. A. 102 (27):9631–9636.
   PubMedGoogle Scholar
• R. Medzhitov. (2001). Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1 (2):135–145.
   PubMedGoogle Scholar
• K. Asehnoune, D. Strassheim, S. Mitra, J.Y. Kim, and E. Abraham. (2004). Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-κB. J. Immunol. 172 (4):2522–2529.
   PubMedGoogle Scholar
• U. Kikkawa, A. Kishimoto, and Y. Nishizuka. (1989). The protein kinase C family: Heterogeneity and its implications. Ann. Rev. Biochem. 58:31–44.
   PubMed Web of Science ®Google Scholar
• Y.G. Ko, J.S. Lee, Y.S. Kang, J.H. Ahn, and J.S. Seo. (1999). TNF-α-mediated apoptosis is initiated in caveolae-like domains. J. Immunol. 162 (12):7217–7223.
   PubMedGoogle Scholar
• D.F. Legler, O. Micheau, M.A. Doucey, J. Tschopp, and C. Bron. (2003). Recruitment of TNF receptor 1 to lipid rafts is essential for TNFα-mediated NF-κB activation. Immunity 18 (5):655–664.
   PubMedGoogle Scholar
• D.A. Brown, and J.K. Rose. (1992). Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (3):533–544.
   PubMedGoogle Scholar
• T. Cinek, and V. Horejsi. (1992). The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J. Immunol. 149 (7):2262–2270.
   PubMedGoogle Scholar
• W. Zhang, R.P. Trible, and L.E. Samelson. (1998). LAT palmitoylation: its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity 9 (2):239–246.
   PubMedGoogle Scholar
• M.P. Lisanti, P.E. Scherer, J. Vidugiriene, Z. Tang, A. Hermanowski-Vosatka, Y.H. Tu, R.F. Cook, and M. Sargiacomo. (1994). Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J. Cell Biol. 126 (1):111–126.
   PubMedGoogle Scholar
• P.W. Janes, S.C. Ley, and A.I. Magee. (1999). Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell Biol. 147 (2):447–461.
   PubMedGoogle Scholar
• K. Simons, and D. Toomre. (2000). Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1 (1):31–39.
   PubMed Web of Science ®Google Scholar
• A. Pfeiffer, A. Böttcher, E. Orsó, M. Kapinsky, P. Nagy, A. Bodnár, I. Spreitzer, G. Liebisch, W. Drobnik, K. Gempel, M. Horn, S. Holmer, T. Hartung, G. Multhoff, G. Schütz, H. Schindler, A. Ulmer, H. Heine, F. Stelter, C. Schütt, G. Rothe, J. Szöllôsi, S. Damjanovich, and G. Schmitz. (2001). Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 31 (11):3153–3164.
   PubMedGoogle Scholar
• S. Olsson, and R. Sundler. (2006). The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol. Immunol. 43 (6):607–612.
   PubMedGoogle Scholar
• M. Triantafilou, K. Miyake, D.T. Golenbock, and K. Triantafilou. (2002). Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115 (12):2603–2611.
   PubMedGoogle Scholar
• J. Wang, and G. Mazza. (2002). Inhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN-γ-activated RAW 264.7 macrophages. J. Agric. Food Chem. 50 (4):4183–4189.
   PubMedGoogle Scholar